The rating downgrade is based on several factors, including ETMC’s weakening financial performance and thinning debt service coverage.
The outlook is negative, reflecting Moody’s Investors Service’s expectation that ETMC’s performance will continue to decline in the near term.
More articles on healthcare finance:
Athenahealth COO sells 4k shares of company stock
Modernizing Medicine seeks to hire 20 medical billing analysts in California
21 latest hospital credit downgrades
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
